Literature DB >> 11916542

Guidelines on endocrine therapy of breast cancer EUSOMA.

R W Blamey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11916542     DOI： 10.1016/s0959-8049(02)00011-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  10 in total

Review 1.  Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women.

Authors:  Susan M Cheer; Greg L Plosker; Dene Simpson; Antona J Wagstaff
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Trends in endocrine therapy and chemotherapy for early breast cancer: a focus on the premenopausal patient.

Authors:  W Jonat; K I Pritchard; R Sainsbury; J G Klijn
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-25       Impact factor: 4.553

Review 3.  How do I follow patients with early breast cancer after completing adjuvant therapy.

Authors:  Jennifer M Matro; Lori J Goldstein
Journal:  Curr Treat Options Oncol       Date:  2014-03

4.  Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study.

Authors:  Maria B Lyng; Anne-Vibeke Lænkholm; Rolf Søkilde; Karina H Gravgaard; Thomas Litman; Henrik J Ditzel
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

5.  miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A.

Authors:  Kazuhiro Ikeda; Kuniko Horie-Inoue; Toshihide Ueno; Takashi Suzuki; Wataru Sato; Takashi Shigekawa; Akihiko Osaki; Toshiaki Saeki; Eugene Berezikov; Hiroyuki Mano; Satoshi Inoue
Journal:  Sci Rep       Date:  2015-08-10       Impact factor: 4.379

6.  microRNA-221 and tamoxifen resistance in luminal-subtype breast cancer patients: A case-control study.

Authors:  Alfiah Amiruddin; Muhammad Nassrum Massi; Andi Asadul Islam; Ilhamjaya Patellongi; Muhammad Yogi Pratama; Noorwati Sutandyo; Rosdiana Natzir; Mochammad Hatta; Nani Harlina Md Latar; Syarifuddin Wahid
Journal:  Ann Med Surg (Lond)       Date:  2021-11-22

7.  Introduction of a breast cancer care programme including ultra short hospital stay in 4 early adopter centres: framework for an implementation study.

Authors:  Mascha de Kok; Caroline N A Frotscher; Trudy van der Weijden; Alfons G H Kessels; Carmen D Dirksen; Cornelis J H van de Velde; Jan A Roukema; Antoine V R J Bell; Fred W van der Ent; Maarten F von Meyenfeldt
Journal:  BMC Cancer       Date:  2007-07-02       Impact factor: 4.430

8.  Management of arthralgias associated with aromatase inhibitor therapy.

Authors:  C Thorne
Journal:  Curr Oncol       Date:  2007-12       Impact factor: 3.677

Review 9.  Role of aromatase inhibitors in breast cancer.

Authors:  R Carpenter; W R Miller
Journal:  Br J Cancer       Date:  2005-08       Impact factor: 7.640

Review 10.  Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer.

Authors:  Marta Venturelli; Giorgia Guaitoli; Claudia Omarini; Luca Moscetti
Journal:  Breast Cancer (Dove Med Press)       Date:  2018-03-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.